PTC Therapeutics Inc - Company Profile
Powered by 
All the sales intelligence you need on PTC Therapeutics Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how PTC Therapeutics Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with PTC Therapeutics Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on PTC Therapeutics Inc patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| US20230381181A1 | Application | Methods for increasing sepiapterin plasma exposure | A61K31/519; A61K9/0053 | November 30, 2023 |
| US11827646B2 | Grant | Compounds for treating spinal muscular atrophy | C07D519/00 | November 28, 2023 |
| JP2023549577A | Application | ハンチントン病の処置において使用するための錠剤及びそれを作製する方法 | A61K31/5025; A61K9/2027; A61K9/2054; A61P25/14; A61P25/28 | November 27, 2023 |
| US20230364029A1 | Application | Polymorphic forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-TRIMETHYL-3,6-DIOXOCYCLOHEXA-1,4-DIENYL)butanamide | A61K31/122; A61K31/164; C07B2200/13; C07B57/00; C07C215/08; C07C215/28; C07C215/30; C07C231/12; C07C235/78; C07C2601/16 | November 16, 2023 |
| EP4241772A3 | Search Report | Verfahren zur herstellung von verbindungen zur behandlung von spinaler muskelatrophie | A61P21/02; C07D471/04; C07D487/04; C07D519/00; A61K31/5025; A61P21/00; A61K31/519; A61P25/28 | November 15, 2023 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer